The Chemours Company
Here’s whether The Chemours Company (CC) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+5.41% over 10 days); strong 1-year return of +97.0%; 3-month momentum positive (+16.1%). Concerns: below the 50-day MA (medium-term momentum negative). Currently 25.5% off its 52-week high. Score: +4/7.
CC is holding above its long-term 200-day MA ($16.75) but has slipped below the 50-day MA ($22.75), pointing to short-term weakness in an otherwise intact trend. An RSI of 30.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +97.0% compares to +27.9% for SPY (beat the market by 69.1%). The current 25.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.